Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

GENTAMICIN - ANVISA Registration 80146502156

Access comprehensive regulatory information for GENTAMICIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502156 and manufactured by B.R.A.H.M.S. GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80146502156
Registration Details
ANVISA Registration Number: 80146502156
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Alinity c Gentamicin Reagent Kit
Risk Class II

Registration Details

80146502156

25351310351201812

56998701000116

Company Information

B.R.A.H.M.S. GMBH
Germany
PT: ALEMANHA

Dates and Status

Jul 23, 2018

VIGENTE

09/18/2025 19:00:01